Date |
Product |
Disease |
Phase |
Company |
Therapeutic area |
2018-06-01
|
nemorexant (ACT-541468) |
insomnia |
3 |
Idorsia (Switzerland) |
CNS diseases |
2018-05-29
|
OLX10010 |
hypertrophic scar |
1 |
Olix Pharmaceuticls (South Korea) |
Dermatological diseases |
2018-05-26
|
atezolizumab (MPDL3280A) and daratumumab |
solid tumors |
1b |
Janssen Biotech, a J&J company (USA - NJ) |
Cancer - Oncology |
2018-05-25
|
THR-149 |
diabetic macular edema |
1 |
Thrombogenics (Belgium) |
Ophtalmological diseases |
2018-05-24
|
BB-401 |
head and neck squamous cell carcinoma (HNSCC) |
2 |
Benitec Biopharma (Australia) |
Cancer - Oncology |
2018-05-24
|
TriMix-MEL (ECI-006) |
metastatic melanoma |
1 |
eTheRNA immunotherapies (Belgium) |
Cancer - Oncology |
2018-05-18
|
burosumab - KRN23 |
X-Linked hypophosphatemia |
3 |
Ultragenyx Pharmaceutical (USA - CA) Kyowa Hakko Kirin (Japan) |
Rare diseases - Genetic diseases - Metabolic diseases |
2018-05-18
|
remetinostat |
early-stage cutaneous T-cell lymphoma (CTCL) |
2 |
Medivir (Sweden) |
Cancer - Oncology |
2018-05-17
|
pamiparib (BGB-290) |
platinum-sensitive recurrent ovarian cancer |
3 |
BeiGene (China) |
Cancer - Oncology |
2018-05-17
|
SYNT001 |
pemphigus (vulgaris or foliaceus) |
1-2 |
Syntimmune (USA - MA) |
Autoimmune diseases - Rare diseases |
2018-05-14
|
ARO-HBV |
chronic hepatitis B virus (HBV) infection |
1-2 |
Arrowhead Pharmaceuticals (USA - CA) |
Infectious diseases |
2018-05-09
|
brilacidin-OM oral rinse |
oral mucositis in patients undergoing chemoradiation therapy for head and neck cancer |
2 |
Cellceutix (USA - MA), now Innovation Pharmaceuticals (USA - MA) |
Cancer - Oncology |
2018-05-08
|
ALG.APV-527 |
5T4-expressing solid tumors. |
preclinical |
Alligator Bioscience (Sweden) Aptevo Therapeutics (USA - WA) |
Cancer - Oncology |
2018-05-08
|
LB-001 |
methylmalonic acidemia (MMA) |
preclinical |
LogicBio Therapeutics (USA - MA) |
Rare diseases - Genetic diseases - Metabolic diseases |
2018-05-03
|
CYAD-01 - NKR-2 (NKG2D CAR T-Cell) |
metastatic colorectal cancer |
1 |
Celyad (Belgium) |
Cancer - Oncology |
2018-05-03
|
CYAD-01 (CAR-T NKG2D) |
colorectal cancer |
1 |
Celyad (Belgium) |
Cancer - Oncology |
2018-05-02
|
alicaforsen enema |
pouchitis |
3 |
Atlantic Healthcare (UK) |
Inflammatory diseases - Gastrointestinal diseases |
2018-05-01
|
MOR106 |
atopic dermatitis |
2 |
Galapagos (Belgium) Morphosys (Germany) |
Autoimmune diseases - Dermatological diseases |
2018-04-27
|
THR-317 and ranibizumab |
diabetic macular edema |
2 |
Thrombogenics (Belgium) |
Ophtalmological diseases |
2018-04-26
|
burtomab (131-I-8H9), now omburtamab |
desmoplastic small round cell tumor (DSRCT) |
1 |
Y-mAbs Therapeutics (USA - NY) |
Cancer - Oncology - Rare diseases |